Real-Time and Retrospective Emotion Awareness With Cognitive Reappraisal Training (NCT07607834) | Clinical Trial Compass
CompletedNot Applicable
Real-Time and Retrospective Emotion Awareness With Cognitive Reappraisal Training
Taiwan42 participantsStarted 2024-01-25
Plain-language summary
This pilot randomized active-comparison study examined two formats of emotional awareness and cognitive reappraisal training for adults with co-occurring anxiety and depressive symptoms. Participants were assigned to either a real-time awareness group or a retrospective awareness group. The real-time awareness group used a smartwatch-based heart-rate prompting system to identify emotions in daily life and later complete cognitive reappraisal exercises. The retrospective awareness group completed daily evening reflection and cognitive reappraisal exercises based on emotional events from that day. The study lasted six weeks and included assessments at baseline, mid-intervention, and post-intervention. Outcomes included anxiety symptoms, depressive symptoms, emotional clarity, mood repair, cognitive reappraisal, expressive suppression, and psychological well-being. The purpose of the study was to examine preliminary patterns of change and compare how the two formats may support emotion regulation processes.
Who can participate
Age range
18 Years – 45 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adults aged 18 to 45 years.
* Self-reported co-occurring anxiety and depressive symptoms.
* Score of 8 or above on the Chinese version of the Beck Anxiety Inventory.
* Score between 14 and 28 on the Chinese version of the Beck Depression Inventory-II.
* Ability to provide written informed consent and complete the study procedures.
Exclusion Criteria:
* Illegal substance use.
* Excessive alcohol or caffeine consumption, defined as more than four caffeinated beverages or four cans of beer per day.
* Major psychiatric disorders or cognitive impairment, such as schizophrenia or neurocognitive disorders.
* Current psychiatric medication use.
* Ongoing psychological or psychiatric treatment.
* Pregnancy or current responsibility for caring for an infant.
* Severe depressive symptoms, defined as a Beck Depression Inventory-II score of 29 or above.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Change in Anxiety Symptoms
Timeframe: Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.
2
Change in Depressive Symptoms
Timeframe: Baseline, mid-intervention approximately 2 weeks after baseline, and post-intervention approximately 6 weeks after baseline.